Use of Sugammadex in Myasthenia Gravis and Becker Muscular Dystrophy: Four Cases

Journal Title: Journal of Neurological Sciences-Turkish - Year 2012, Vol 29, Issue 4

Abstract

Myasthenia gravis is an antibody-mediated autoimmune disease targeting nicotinic acid acetylcholine receptors in neuromuscular junctions. In myasthenia gravis, the number of nicotinic acid acetylcholine receptors is significantly reduced. This condition leads to muscular weakness and deserves special attention in terms of respiratory muscles. Becker muscular dystrophy is an X-linked recessive inherited disorder characterized by slowly progressive muscle weakness of the legs and pelvis. Sugammadex is a hydrophilic cyclodextrin molecule that has a lipophilic nucleus. It is an innovative molecule which terminates the effects of steroidal neuromuscular blocking agents via encapsulation. This is a report of the use of sugammadex in patients with MG and Becker muscular dystrophy. Three patients with myasthenia gravis; 55, 45 and 2.5 year-old; were enrolled the surgery under general anesthesia for the disc hernia repair, abdominal hysterectomy, and correcting of cataract, respectively. Additionally, a five-year-old patient with Becker muscular dystrophy was scheduled for circumcision and orchiopexy under general anesthesia. In all patients, rocuronium as a muscle relaxant and sugammadex for the reverse of rocuronium were administered. Tracheal extubation was achieved in all patients at the end of operations without complications. The use of a combination of rocuronium-sugammadex seems safe in muscle diseases without the development of any possible complications.

Authors and Affiliations

Yasemin USTUN, Binnur SARIHASAN, Ismail KOCAMANOGLU, Seda YEGIN, Hatice AZAR

Keywords

Related Articles

Multipl Sklerozda Kısa Süreli Yüksek Doz Puls Kortikoterapinin Kemik Mineral Yoğunluğu Üzerine Etkisinin Değerlendirilmesi

Amaç: Osteoporoz uzun süreli kortikosteroid kullanımının en sık yan etkilerinden biridir. Multipl skleroz hastalarına hayatlarının belirli dönemlerinde atak tedavisi olarak kısa süreli yüksek doz puls metilprednizolon uy...

Thymectomy In Myastenia Gravis: Comparison With Conservative Therapy

Aim: To assess the efficacy of thymectomy on prognosis in myasthenia gravis (MG). Method: The demographical and clinical features of 40 thymectomised patients followed in our neuromuscular day clinic were analysed and c...

Paget’s Disease Of The Spine With Low Bone Alkaline Phosphatase

We present a case of 35-year-old man who was referred to us with a preliminary diagnosis of multiple spinal metastasis. Laboratory studies have shown a high serum alkaline phosphatase and a low bone alkaline phosphatase...

Late Onset Poststroke Seizures

The most common cause of seizures is cerebrovascular disease in elderly population. Late onset seizures are not investigated as well as early onset seizures in patients with stroke. There is no common consensus about cli...

Ağır Koah'li Hastalarda Kantitatif EEG Analizi: Kronik Hipoksemik Dejenerasyona Ait İpuçları

Amaç: Bu kesitsel klinik ve elektrofizyolojik çalışma ağır KOAH’lı hastalarda kognitif bozulmanın elektrofizyolojik gösterglerini kantitatif EEG (KEEG) yardımı ile belirlemek amacı ile yapıldı. Gereç ve yöntem: 33 ağır...

Download PDF file
  • EP ID EP93047
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Yasemin USTUN, Binnur SARIHASAN, Ismail KOCAMANOGLU, Seda YEGIN, Hatice AZAR (2012). Use of Sugammadex in Myasthenia Gravis and Becker Muscular Dystrophy: Four Cases. Journal of Neurological Sciences-Turkish, 29(4), 826-831. https://europub.co.uk/articles/-A-93047